On Facebook, moms debate if the vaccine could harm their kids' reproductive health. And in tweets, people share claims about adverse reactions to the shot. They're all talking about HPV ...
The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18.
The vaccine that protects against four HPV strains is the first shot for males on the Chinese mainland. It was first authorized for use among females aged 9 to 45 in 2017 in the nation.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果